Primecap Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.39B | Buy |
25,204,538
+74,378
| +0.3% | +$4.03M | 1.1% | 27 |
|
|
2025
Q4 | $1.23B | Sell |
25,130,160
-636,790
| -2% | -$29.7M | 0.93% | 31 |
|
|
2025
Q3 | $1.11B | Sell |
25,766,950
-1,959,830
| -7% | -$76.6M | 0.85% | 37 |
|
|
2025
Q2 | $1.06B | Buy |
27,726,780
+2,018,760
| +8% | +$77.1M | 0.84% | 35 |
|
|
2025
Q1 | $996M | Buy |
25,708,020
+446,360
| +2% | +$16.3M | 0.82% | 39 |
|
|
2024
Q4 | $854M | Buy |
25,261,660
+10,407,905
| +70% | +$375M | 0.66% | 43 |
|
|
2024
Q3 | $607M | Buy |
14,853,755
+342,365
| +2% | +$14M | 0.45% | 55 |
|
|
2024
Q2 | $559M | Buy |
14,511,390
+1,773,020
| +14% | +$74.6M | 0.4% | 57 |
|
|
2024
Q1 | $546M | Buy |
12,738,370
+649,000
| +5% | +$26.8M | 0.41% | 60 |
|
|
2023
Q4 | $448M | Buy |
12,089,370
+30,600
| +0.3% | +$1.1M | 0.35% | 64 |
|
|
2023
Q3 | $437M | Buy |
12,058,770
+287,000
| +2% | +$10.2M | 0.37% | 64 |
|
|
2023
Q2 | $420M | Buy |
11,771,770
+1,900,260
| +19% | +$68.2M | 0.35% | 68 |
|
|
2023
Q1 | $351M | Buy |
9,871,510
+6,105,590
| +162% | +$214M | 0.31% | 75 |
|
|
2022
Q4 | $132M | Buy |
3,765,920
+3,324,800
| +754% | +$111M | 0.12% | 119 |
|
|
2022
Q3 | $13M | Hold |
441,120
| – | – | 0.01% | 235 |
|
|
2022
Q2 | $24M | Hold |
441,120
| – | – | 0.02% | 212 |
|
|
2022
Q1 | $24M | Hold |
441,120
| – | – | 0.02% | 222 |
|
|
2021
Q4 | $24.3M | Hold |
441,120
| – | – | 0.02% | 232 |
|
|
2021
Q3 | $21.1M | Hold |
441,120
| – | – | 0.01% | 241 |
|
|
2021
Q2 | $22M | Sell |
441,120
-6,320
| -1% | -$304K | 0.01% | 237 |
|
|
2021
Q1 | $20M | Hold |
447,440
| – | – | 0.01% | 239 |
|
|
2020
Q4 | $20.6M | Hold |
447,440
| – | – | 0.02% | 231 |
|
|
2020
Q3 | $21.1M | Hold |
447,440
| – | – | 0.02% | 216 |
|
|
2020
Q2 | $22.8M | Hold |
447,440
| – | – | 0.02% | 200 |
|
|
2020
Q1 | $21.2M | Hold |
447,440
| – | – | 0.02% | 188 |
|
|
2019
Q4 | $26.3M | Sell |
447,440
-2,560
| -0.6% | -$142K | 0.02% | 200 |
|
|
2019
Q3 | $24M | Sell |
450,000
-1,680
| -0.4% | -$86.4K | 0.02% | 195 |
|
|
2019
Q2 | $22.6M | Sell |
451,680
-9,840
| -2% | -$494K | 0.02% | 211 |
|
|
2019
Q1 | $24.1M | Hold |
461,520
| – | – | 0.02% | 208 |
|
|
2018
Q4 | $22M | Sell |
461,520
-213,388
| -32% | -$10.5M | 0.02% | 205 |
|
|
2018
Q3 | $33.9M | Sell |
674,908
-163,040
| -19% | -$8.28M | 0.02% | 205 |
|
|
2018
Q2 | $42.2M | Hold |
837,948
| – | – | 0.03% | 186 |
|
|
2018
Q1 | $40.9M | Sell |
837,948
-20,080
| -2% | -$935K | 0.03% | 185 |
|
|
2017
Q4 | $38M | Sell |
858,028
-2,400
| -0.3% | -$111K | 0.03% | 184 |
|
|
2017
Q3 | $43.7M | Hold |
860,428
| – | – | 0.04% | 180 |
|
|
2017
Q2 | $46.4M | Sell |
860,428
-14,760
| -2% | -$787K | 0.04% | 182 |
|
|
2017
Q1 | $46.1M | Hold |
875,188
| – | – | 0.04% | 173 |
|
|
2016
Q4 | $42.1M | Sell |
875,188
-12,080
| -1% | -$597K | 0.04% | 169 |
|
|
2016
Q3 | $47.8M | Sell |
887,268
-5,520
| -0.6% | -$303K | 0.05% | 165 |
|
|
2016
Q2 | $48.4M | Sell |
892,788
-720
| -0.1% | -$37.9K | 0.05% | 168 |
|
|
2016
Q1 | $45.3M | Sell |
893,508
-2,506,720
| -74% | -$125M | 0.05% | 172 |
|
|
2015
Q4 | $171M | Sell |
3,400,228
-12,080
| -0.4% | -$616K | 0.18% | 103 |
|
|
2015
Q3 | $164M | Sell |
3,412,308
-264,000
| -7% | -$13.7M | 0.18% | 103 |
|
|
2015
Q2 | $191M | Sell |
3,676,308
-2,040
| -0.1% | -$115K | 0.19% | 101 |
|
|
2015
Q1 | $212M | Sell |
3,678,348
-220,240
| -6% | -$12.6M | 0.21% | 96 |
|
|
2014
Q4 | $208M | Sell |
3,898,588
-1,120
| -0% | -$62.7K | 0.21% | 95 |
|
|
2014
Q3 | $224M | Sell |
3,899,708
-225,451
| -5% | -$13.8M | 0.24% | 86 |
|
|
2014
Q2 | $276M | Sell |
4,125,159
-3,217,143
| -44% | -$218M | 0.3% | 77 |
|
|
2014
Q1 | $490M | Sell |
7,342,302
-656,800
| -8% | -$44.4M | 0.56% | 51 |
|
|
2013
Q4 | $534M | Sell |
7,999,102
-63,822
| -0.8% | -$4.14M | 0.64% | 37 |
|
|
2013
Q3 | $506M | Sell |
8,062,924
-37,760
| -0.5% | -$2.43M | 0.67% | 41 |
|
|
2013
Q2 | $506M | Buy |
+8,100,684
| New | +$514M | 0.72% | 34 |
|
Other funds holding GSK
JEST
Primecap Management's GSK Position: Q1 2026 in Review
Primecap Management increased its GSK (GSK) stake by 0.3% in Q1 2026, buying an estimated $4.03M and bringing the position to 25,204,538 shares worth $1.39B. The position accounts for 1.1% of the portfolio, ranked #27.
Primecap Management first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Primecap Management held 25,204,538 shares of GSK worth $1.39B as of Q1 2026.
- Primecap Management bought 74,378 GSK shares in Q1 2026, an estimated $4.03M.
- GSK made up 1.1% of Primecap Management's portfolio in Q1 2026, its #27 holding.
- Primecap Management first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Primecap Management's 13F filing for Q1 2026, filed 11 May 2026.